Skip to main content
Fig. 1 | BMC Urology

Fig. 1

From: Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma

Fig. 1

Kaplan–Meier curves depicting A PFS, B CSS, and C OS of patients with aUC treated with full-dose GC, dose-reduced GC, or GCa. Abbreviations: aUC Advanced urothelial carcinoma, CSS Cancer-specific survival, GC Gemcitabine/cisplatin, GCa Gemcitabine/carboplatin, OS Overall survival, PFS Progression-free survival

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us